Zhengnian Li, PhD
Zhengnian graduated from GIBH, CAS (Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences) with a PhD in medicinal chemistry. During his Ph.D, he focused on total synthesis of several active natural products. He joined Gray lab in 2017 and is interested in the development of novel small-molecule kinase inhibitors.
Zhengnian graduated from GIBH, CAS (Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences) with a PhD in medicinal chemistry. During his Ph.D, he focused on total synthesis of several active natural products. He joined Gray lab in 2017 and is interested in the development of novel small-molecule kinase inhibitors.